STAT3-mediated activation of microRNA cluster 17∼92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma

被引:45
作者
Spaccarotella, Elisa [1 ,2 ]
Pellegrino, Elisa [1 ,2 ]
Ferracin, Manuela [3 ,4 ]
Ferreri, Cristina [1 ,2 ]
Cuccuru, Giuditta [1 ,2 ]
Liu, Cuiling [5 ]
Iqbal, Javeed [5 ]
Cantarella, Daniela [6 ]
Taulli, Riccardo [2 ,7 ]
Provero, Paolo [1 ,8 ]
Di Cunto, Ferdinando [1 ,8 ]
Medico, Enzo [6 ]
Negrini, Massimo [3 ,4 ]
Chan, Wing C. [5 ]
Inghirami, Giorgio [1 ,2 ,9 ,10 ]
Piva, Roberto [1 ,2 ,9 ,10 ]
机构
[1] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10124 Turin, Italy
[2] CeRMS, Turin, Italy
[3] Univ Ferrara, LTTA, I-44100 Ferrara, Italy
[4] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy
[5] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[6] Univ Turin, Inst Canc Res & Treatment, Lab Funct Genom, I-10124 Turin, Italy
[7] Univ Turin, Dept Oncol, I-10124 Turin, Italy
[8] Univ Turin, Mol Biotechnol Ctr, I-10124 Turin, Italy
[9] NYU, Sch Med, Dept Pathol, New York, NY USA
[10] NYU, Sch Med, NYU Canc Ctr, New York, NY USA
关键词
PERIPHERAL T-CELL; STAT3; ACTIVATION; DOWN-REGULATION; LUNG-CANCER; KINASE; EXPRESSION; TARGET; INHIBITOR; GENE; IDENTIFICATION;
D O I
10.3324/haematol.2013.088286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic anaplastic large cell lymphoma is a category of T-cell non-Hodgkin's lymphoma which can be further subdivided into two distinct entities (ALK(+) and ALK(-)) based on the presence or absence of ALK gene rearrangements. Among several pathways triggered by ALK signaling, constitutive activation of STAT3 is strictly required for ALK-mediated transformation and survival. Here we performed genome-wide microRNA profiling and identified 48 microRNA concordantly modulated by the inducible knock-down of ALK and STAT3. To evaluate the functional role of differentially expressed miRNA, we forced their expression in ALK(+) anaplastic large cell lymphoma cells, and monitored their influence after STAT3 depletion. We found that the expression of the microRNA-17 similar to 92 cluster partially rescues STAT3 knock-down by sustaining proliferation and survival of ALK+ cells. Experiments in a xenograft mouse model indicated that forced expression of microRNA-17 similar to 92 interferes with STAT3 knock-down in vivo. High expression levels of the microRNA-17 similar to 92 cluster resulted in down-regulation of BIM and TGF beta RII proteins, suggesting that their targeting might mediate resistance to STAT3 knock-down in anaplastic large cell lymphoma cells. We speculate that the microRNA-17 similar to 92 cluster is involved in lymphomagenesis of STAT3(+) ALCL and that its inhibition might represent an alternative avenue to interfere with ALK signaling in anaplastic large cell lymphomas.
引用
收藏
页码:116 / 124
页数:9
相关论文
共 50 条
[1]   NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells [J].
Ambrogio, Chiara ;
Martinengo, Cinzia ;
Voena, Claudia ;
Tondat, Fabrizio ;
Riera, Ludovica ;
di Celle, Paola Francia ;
Inghirami, Giorgio ;
Chiarle, Roberto .
CANCER RESEARCH, 2009, 69 (22) :8611-8619
[2]   Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma [J].
Amin, HM ;
McDonnell, TJ ;
Ma, YP ;
Lin, Q ;
Fujio, Y ;
Kunisada, K ;
Leventaki, V ;
Das, P ;
Rassidakis, GZ ;
Cutler, C ;
Medeiros, LJ ;
Lai, R .
ONCOGENE, 2004, 23 (32) :5426-5434
[3]   Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma [J].
Amin, HM ;
Medeiros, LJ ;
Ma, Y ;
Feretzaki, M ;
Das, P ;
Leventaki, V ;
Rassidakis, GZ ;
O'Connor, SL ;
McDonnell, TJ ;
Lai, R .
ONCOGENE, 2003, 22 (35) :5399-5407
[4]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[5]   Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway [J].
Brock, Matthias ;
Trenkmann, Michelle ;
Gay, Renate E. ;
Michel, Beat A. ;
Gay, Steffen ;
Fischler, Manuel ;
Ulrich, Silvia ;
Speich, Rudolf ;
Huber, Lars C. .
CIRCULATION RESEARCH, 2009, 104 (10) :1184-U139
[6]  
Cabanillas Fernando, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS87, DOI 10.1016/j.clml.2011.03.029
[7]   Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors [J].
Ceccon, Monica ;
Mologni, Luca ;
Bisson, William ;
Scapozza, Leonardo ;
Gambacorti-Passerini, Carlo .
MOLECULAR CANCER RESEARCH, 2013, 11 (02) :122-132
[8]   CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers [J].
Cheng, Mangeng ;
Quail, Matthew R. ;
Gingrich, Diane E. ;
Ott, Gregory R. ;
Lu, Lihui ;
Wan, Weihua ;
Albom, Mark S. ;
Angeles, Thelma S. ;
Aimone, Lisa D. ;
Cristofani, Flavio ;
Machiorlatti, Rodolfo ;
Abele, Cristina ;
Ator, Mark A. ;
Dorsey, Bruce D. ;
Inghirami, Giorgio ;
Ruggeri, Bruce A. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) :670-679
[9]   Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target [J].
Chiarle, R ;
Simmons, WJ ;
Cai, HY ;
Dhall, G ;
Zamo', A ;
Raz, R ;
Karras, JG ;
Levy, DE ;
Inghirami, G .
NATURE MEDICINE, 2005, 11 (06) :623-629
[10]   The anaplastic lymphoma kinase in the pathogenesis of cancer [J].
Chiarle, Roberto ;
Voena, Claudia ;
Ambrogio, Chiara ;
Piva, Roberto ;
Inghirami, Giorgio .
NATURE REVIEWS CANCER, 2008, 8 (01) :11-23